Search Browse Earnings

TuHURA Biosciences, Inc./NV — SlamSEC

TuHURA Biosciences, Inc./NV

Nasdaq:HURA

Pharmaceutical Preparations·TAMPA, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

—

Net Income

-$29.3M

FY 2024

EPS (Diluted)

-$2.47

FY 2024

Stock Price

$1.80

+6.5%

2026-03-10

52W Range

$0.41 – $4.44

P/E Ratio

-0.7x

Market Cap

$92.3M

Cash

$3.7M

FY 2024

Total Debt

$1,117

FY 2019

Net Cash

$3.7M

FY 2019

Enterprise Value

$88.6M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—